In a placebo-controlled trial, which group receives an inert substance designed to resemble the experimental treatment?

• A. Receives the active treatment
• B. Receives standard care
• C. Receives a placebo
• D. Receives no treatment

Answer: (C)

The main idea being tested is how placebo controls help isolate the true effect of a treatment. In a placebo-controlled trial, an inert substance is given in a way that mirrors the experimental treatment so participants cannot tell which group they’re in. This preserves blinding and helps separate improvements caused by expectations (the placebo effect) from improvements caused by the active treatment itself. The group that receives this inert substance designed to resemble the treatment is the placebo group. This is different from the group that gets the active treatment, which is the experimental or active-arm group. It’s also distinct from standard care, which means usual management without the experimental agent, and from receiving no treatment at all, which would lack any trial-related intervention. The key point is that the placebo looks and, as much as possible, feels like the real treatment to control for bias and placebo response.